CTIS.eu › Cities › France › Nantes
Nantes
France
800 total trials
369 recruiting
2024-514633-38-00
5
Crohn’s Disease
2024-514659-13-00
5
Patients with severe forms of Recurrent Aphthous Stomatitis (RAS)
2024-514848-88-00
4
Folliculitis decalvans
2024-514964-24-00
5
ulcerative colitis
2024-515107-19-00
5
Patients (male or female) ≥18 years old with Detrusor overactivity (DO
2024-515362-13-00
10
Philadelphia-negative myeloproliferative neoplasms are frequent and ch
2024-515603-19-01
4
Localized digestive Neuroendocrine Carcinomas
2024-515860-29-00
5
kidney transplantation
2024-515956-19-00
5
Chondrocalcinosis
2024-516018-39-00
5
Erythema multiforme (EM) in its severe form managed at the hospital
2024-516115-24-00
9
High risk relapsed neuroblastoma (relapsed or progressed after being d
2024-516257-44-00
4
Multiple myeloma
2024-516335-27-00
5
anti-MAG neuropathy
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
2024-517030-17-00
4
Newly diagnosed or relapsing Giant-cell arteritis
2024-517595-38-00
5
Thrombotic episodes in superficial venous malformations in children
2024-518138-10-00
4
Patients with DMMR and/or MSI metastatic colorectal cancer
2024-518437-28-00
5
Sickle cell disease
2024-518516-39-00
4
Systemic sclEroderma
2024-519166-48-01
4
Posterior Urethral Valves
2024-519402-12-00
5
uncomplicated appendicitis
2024-519504-27-00
5
Relapsed Refractory Multiple Myeloma
2024-519986-23-00
5
The study will involve adult women and men from 16 French centers who
2024-520089-70-00
5
Cutaneous lupus erythematosus
Showing 25–48 of 800 trials